ProPhase Labs, Inc. (PRPH)

Market Cap	18.26M
Revenue (ttm)	12.75M
Net Income (ttm)	-27.76M
Shares Out	23.87M
EPS (ttm)	-1.51
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	44,248
Open	0.760
Previous Close	0.760
Day's Range	0.726 - 0.765
52-Week Range	0.660 - 7.480
Beta	-0.10
Analysts	Strong Buy
Price Target	11.00 (+1,337.91%)
Earnings Date	Nov 13, 2024

About PRPH

ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. It offers contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, includi...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Jan 16, 1997
• Employees: 113
• Stock Exchange: NASDAQ
• Ticker Symbol: PRPH
• Website: https://www.prophaselabs.com

Analyst Forecast

According to one analyst, the rating for PRPH stock is "Strong Buy" and the 12-month stock price forecast is $11.0.

Price Target

$11.0

(1,337.91% upside)

Analyst Consensus: Strong Buy